LIFE SCIENCES
On the Hunt for a Productive New Biomanufacturing Site? Real estate and facility strategy can fuel efficiency, scale, and speed to market for your new biomanufacturing operation. By Travis McCready, Executive Director, U.S. Life Sciences Markets, JLL
A
Courtesy: ScieGen Pharmaceuticals
logics therapies, the industry response to COVID-19 will mid explosive demand for biology-based have lasting impact, too. Urgent vaccine production is innovation, many biomanufacturing organizations driving a reinvention of life sciences manufacturing and are expanding their footprints, requiring creating a ripple effect of accelerated production. Since advanced real estate strategies to optimize their growth the pandemic began, 600 tests, drugs, and devices were plans. With shrewd site selection, workplace design, granted emergency-use and facility management, authorizations, a previlaunching your new ously seldom-used regusite can be a boon to latory pathway, with many production — while expected to gain Phase fueling efficiency and II approval over the next attracting prize talent three years. Additionally, over the long term. broad-based support for Expansion may well be reshoring of manufactururgent, considering growing will likely increase ing pressure for warppotential speed to market speed innovation and proand profitability into the duction. Today’s biologics future. are supporting a global patient base that’s only going to increase. Thanks Critical Key Steps ScieGen Pharmaceuticals’ $15.5 million expansion project to continuing breakTo keep up with all in Hauppauge, N.Y., involves converting 65,000 square throughs in medicine, the momentum, biotech feet of existing warehouse space into new lab and office facilities. more people live longer innovators need access to lives — and seek out more well-located, compliancetherapies as they age. Meanwhile, millennials are reachforward, talent-friendly manufacturing facilities. Following their earning potential, and many prioritize spending ing are three critical key steps to accelerate opening on personalized care. — and position the location for longer-term agility and Worldwide pharmaceutical sales are predicted to esinnovation. calate at a compound annual growth rate (CAGR) of 7.4 percent through 2026, to nearly $1.4 trillion in sales, Step 1: according to JLL’s 2021 Life Sciences Real Estate OutFoster innovation with look.1 This represents a major spike in the next six years tech-fueled site selection. compared with the previous six, when sales grew at just Choosing the right location is critical to efficiency, 2.9 percent. Notably, much of this growth is expected compliance, and talent considerations alike. You’ll need from biotechnology-driven therapeutics sales, which on to weigh a range of competing criteria, including proxtheir own are on pace to grow at a momentous 10.1 perimity to research and development (R&D) facilities, supcent through 2026. ply partners, and labor pool. In addition to meeting rising demand for general bioFor example, choosing a Good Manufacturing Practic-
20
AREA DEVELOPMENT
OnTheHuntLifeScience.indd 20
for free site information, visit us online at www.areadevelopment.com
12/1/21 12:48 PM
